| Issue Type | XXXX |
|---|---|
| Country | Spain |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2028-10-15 |
| Par Value | 200000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 705.00 |
| Coupon | 4.75 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 705.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Grifols SA corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million USD and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Grifols SA, founded in 1940 and headquartered in Barcelona, Spain, is a global healthcare company dedicated to improving the health and well-being of people through the development of life-saving therapies. The company specializes in the collection and processing of human plasma and offers a range of products for the treatment of various medical conditions, particularly in the fields of hematology, immunology, and infectious diseases.